A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Inclusion Criteria:

• Have a diagnosis of HS for at least 12 months.

• Have HS lesions in at least 2 distinct anatomical regions. At least 1 of the lesionsmust be at least Hurley Stage II or III.

• Have an (abscess plus inflammatory nodule) count of at least 5.

• Agree to use topical antiseptics daily.

• Had an inadequate response or intolerance to a 28-day course of oral antibiotics.

Exclusion Criteria:

• Have more than 20 draining fistulae.

• Have had surgical treatment for HS in the last 4 weeks before randomization.

• Have an active skin disease or condition, that could interfere with the assessmentof HS.

• Have a current or recent acute, active infection.

• Are immunocompromised.

• Have a history of chronic alcohol abuse, IV drug abuse, or other illicit drug abusewithin 1 year before screening.